首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3045篇
  免费   255篇
  国内免费   97篇
耳鼻咽喉   11篇
儿科学   29篇
妇产科学   27篇
基础医学   607篇
口腔科学   136篇
临床医学   258篇
内科学   679篇
皮肤病学   56篇
神经病学   245篇
特种医学   16篇
外国民族医学   1篇
外科学   149篇
综合类   193篇
预防医学   54篇
眼科学   13篇
药学   665篇
中国医学   88篇
肿瘤学   170篇
  2024年   8篇
  2023年   36篇
  2022年   42篇
  2021年   108篇
  2020年   72篇
  2019年   80篇
  2018年   84篇
  2017年   90篇
  2016年   91篇
  2015年   117篇
  2014年   156篇
  2013年   350篇
  2012年   160篇
  2011年   179篇
  2010年   156篇
  2009年   143篇
  2008年   151篇
  2007年   123篇
  2006年   130篇
  2005年   130篇
  2004年   125篇
  2003年   109篇
  2002年   84篇
  2001年   85篇
  2000年   40篇
  1999年   54篇
  1998年   72篇
  1997年   59篇
  1996年   45篇
  1995年   45篇
  1994年   41篇
  1993年   28篇
  1992年   23篇
  1991年   18篇
  1990年   30篇
  1989年   7篇
  1988年   6篇
  1987年   14篇
  1986年   9篇
  1985年   23篇
  1984年   8篇
  1983年   14篇
  1982年   10篇
  1981年   9篇
  1980年   8篇
  1979年   9篇
  1978年   6篇
  1976年   2篇
  1975年   3篇
  1968年   2篇
排序方式: 共有3397条查询结果,搜索用时 31 毫秒
91.
J Oral Pathol Med (2010) 39 : 753–760 Background: There are several kinds of oral soft tissue lesions that are common manifestations observed in human immunodeficiency virus (HIV)‐infected children; for example, linear gingival erythema (LGE) that is a distinctive fiery red band along the margin of the gingivae. The etiology and pathogenesis of LGE are questionable, but a candidal origin has been suggested. Proteases are key virulence attributes produced by a variety of pathogenic fungi, including Candida. The objective of the present study is to identify the protease production in Candida species including, C. albicans (n = 5), C. dubliniensis (n = 1) and C. tropicalis (n = 1), isolated directly from typical LGE lesions observed in six HIV‐positive children, and also to test the effect of a serine protease inhibitor on the interaction of Candida spp. and epithelial cells in vitro. Methods: The ability of Candida strains to release proteases in the culture supernatant fluids was visualized by gelatin‐SDS–PAGE. Gel strips containing 30‐fold concentrated supernatant (1.5 × 108 yeasts) were incubated at 37°C for 48 h in 50 mM sodium phosphate buffer, pH 5.5. The concentrated supernatants were also incubated with fibronectin, laminin, immunoglobulin G, bovine serum albumin and human serum albumin. The effect of serine protease inhibitor on the interaction of Candida spp. and epithelial cells (MA 104) was measured after pre‐treatment of fungi with the inhibitor (phenylmethylsulphonyl fluoride, PMSF). Results: All the extracellular proteases were completely inhibited by PMSF, identifying these activities as serine‐type proteases. Interestingly, a common 62‐kDa serine protease was observed in all Candida strains. The culture supernatants, rich in serine protease activities, cleaved several soluble proteinaceous substrates. Additionally, we demonstrated that pre‐treatment of C. albicans, C. dubliniensis and C. tropicalis with PMSF diminished the interaction with epithelial cells. Conclusions: Collectively, our results show that Candida spp. isolated from LGE lesions produced and secreted serine proteases and these enzymes may be involved in the initial colonization events.  相似文献   
92.
93.
94.
95.
96.
The 32kD membrane protein stomatin was first studied because it is deficient from the red cell membrane in two forms of the class of haemolytic anaemias known as "hereditary stomatocytosis." The hallmark of these conditions is a plasma membrane leak to the monovalent cations Na+ and K+: the protein is missing only in the most severely leaky of these conditions. No mutation has ever been found in the stomatin gene in these conditions. Stomatin-like proteins have been identified in all three domains of biology, yet their function remains enigmatic. Although the murine knock-out is without phenotype, we have identified a family showing a splicing defect in the stomatin mRNA, in which affected children showed a catastrophic multisystem disease not inconsistent with the now-known wide tissue distribution of stomatin. We report here a study of strongly homologous stomatin-like genes in prokaryotes, which reveals a close connection with a never-studied gene erroneously known as "nfed." This gene codes for a hydrophobic protein with a probable serine protease motif. It is possible that these stomatin-like genes and those which are known as"nfed" form an operon, suggesting that the two protein products are aimed at a common function. The corollary is that stomatin could be a partner protein for a membrane-bound proteolytic process, in both prokaryotes and in eukaryotes generally: this idea is consistent with experimental evidence.  相似文献   
97.
目的研究半胱氨酸蛋白酶Caspase-3抑制剂Ac-DEVD-CMK及Calpain抑制剂ALLN干预治疗对大鼠局灶性脑缺血/再灌注模型Calpain表达的影响。方法大鼠随机分为经左侧侧脑室注射Ac-DEVD-CMK(DEVD组)、ALLN(ALLN组)、二者联合(DEVD+ALLN组)或溶剂二甲基亚砜组(DMSO组),以及缺血对照组(MCAO组),诱导左侧MCA缺血2h,再灌注24或48h;再灌注24h进行TTC染色观察梗死灶的形成情况;分别通过原位杂交和免疫组化技术检测鼠脑中Calpain mRNA及活性蛋白的表达。结果DMSO组的各项指标与MCAO组差异无显著性;DEVD组或ALLN组缺血侧脑中Calpain mRNA及活性蛋白的表达均明显减少,二者合用作用最强。结论Caspase-3与Calpain均在缺血性脑损伤中起重要作用,针对它们进行治疗干预具有潜在的临床应用价值。  相似文献   
98.
杨健  张芳  杨靖翔  余睿  郭咸希 《中国药师》2015,(10):1638-1642
摘 要 目的: 寻找抗EV71病毒新化合物。方法: 采用分子模拟技术,以EV71病毒3C蛋白酶活性口袋为靶,设计二肽、三肽,四肽,五肽和六肽等多个系列寡肽化合物,合成对接评分较高的寡肽化合物并进行抗EV71病毒活性筛选。结果: 五肽对接评分高于其他系列寡肽,显示五肽化合物与EV71 病毒3C蛋白酶有更强的键合力。研究中合成了两个评分较高的五肽化合物25和化合物16,体外抗EV71病毒活性实验显示化合物25活性较强(EC50=1.36 μmol·L-1,CC50=211.94 μmol·L-1, SI=155.84),而化合物16则无明显活性。结论:五肽化合物25可作为抗EV71病毒新骨架开展进一步研究。  相似文献   
99.

Aim:

Saquinavir (SQV) is the first protease inhibitor for the treatment of HIV infection, but with poor solubility. The aim of this study was to prepare a colloidal nanocrystal suspension for improving the oral absorption of SQV.

Methods:

SQV nanocrystals were prepared using anti-solvent precipitation–high pressure homogenization method. The nanocrystals were characterized by a Zetasizer and transmission electron microscopy (TEM). Their dissolution, cellular uptake and transport across the human colorectal adenocarcinoma cell line (Caco-2) monolayer were investigated. Bioimaging of ex vivo intestinal sections of rats was conducted with confocal laser scanning microscopy. Pharmacokinetic analysis was performed in rats administered nanocrystal SQV suspension (50 mg/kg, ig), and the plasma SQV concentrations were measured with HPLC.

Results:

The SQV nanocrystals were approximately 200 nm in diameter, with a uniform size distribution. The nanocrystals had a rod-like shape under TEM. The dissolution, cellular uptake, and transport across a Caco-2 monolayer of the nanocrystal formulation were significantly improved compared to those of the coarse crystals. The ex vivo intestinal section study revealed that the fluorescently labeled nanocrystals were located in the lamina propria and the epithelium of the duodenum and jejunum. Pharmacokinetic study showed that the maximal plasma concentration (Cmax) was 2.16-fold of that for coarse crystalline SQV suspension, whereas the area under the curve (AUC) of nanocrystal SQV suspension was 1.95-fold of that for coarse crystalline SQV suspension.

Conclusion:

The nanocrystal drug delivery system significantly improves the oral absorption of saquinavir.  相似文献   
100.
Introduction: The introduction of direct-acting antiviral (DAA) agents has revolutionized the treatment of hepatitis C virus (HCV) chronic infection. Non-structural 3 protease inhibitors are currently the most numerous class of DAAs on the market.

Areas covered: This review mainly focuses on the tolerability and safety profile of asunaprevir (ASV)-containing DAA regimens. ASV is a second-wave protease inhibitor currently in Phase III clinical development in most countries and already available in Japan.

Expert opinion: ASV shows potent antiviral effect and clinical efficacy on HCV genotypes 1 and 4. The all-oral combination daclatasvir/ASV reached high eradication rates in HCV genotype 1b and 4 infection, and a lower efficacy in genotype 1a infection. ASV presents a low potential for drug–drug interaction and a good tolerability as part of multiple, including all-oral, regimens. ASV is associated with a transient and usually mild increase in aminotransferase levels in a low percentage of cases. Due to the impaired pharmacokinetic profile observed in advanced liver disease, ASV use in patients with moderate or severe hepatic impairment is not allowed. In conclusion, ASV represents a powerful weapon against HCV infection and has to be considered an optimal option as a component of genotype tailored interferon-free combinations.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号